↓ Skip to main content

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
Published in
Journal for Immunotherapy of Cancer, November 2014
DOI 10.1186/2051-1426-2-s3-p81
Authors

Gary D Steinberg, Neal Shore, Lawrence Karsh, James Bailen, Michael Woods, Mark Schoenberg, Taylor H Schreiber, Melissa Price

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 23%
Student > Bachelor 2 15%
Researcher 2 15%
Student > Master 2 15%
Lecturer 1 8%
Other 0 0%
Unknown 3 23%
Readers by discipline Count As %
Medicine and Dentistry 5 38%
Immunology and Microbiology 2 15%
Mathematics 1 8%
Psychology 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Other 0 0%
Unknown 3 23%